Mihaela Gamala1,2, Johannes W G Jacobs1, Jaap M van Laar1. 1. Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands. 2. Department of Rheumatology, Northwest Clinics, Alkmaar and Den Helder, The Netherlands.
Abstract
OBJECTIVE: This study aimed to assess the utility of dual energy CT (DECT) for diagnosing gout. METHODS: A systematic literature search was performed in PubMed, EMBASE and Cochrane Library. Studies evaluating the utility of DECT for diagnosing gout were included. Reference standards were detection of monosodium urate crystals at SF assessment or a validated set of criteria. The methodological quality of studies was evaluated according to the Quality Assessment of Diagnostic Accuracy Studies (QUADAS)-2 criteria. Data from person-based and joint-/localization-based evaluations were pooled separately, and subgroup analyses for disease stage/duration and reference standard were performed. RESULTS: Ten studies were included; in person-based evaluations, the pooled (95% CI) sensitivity and specificity were 0.81 (0.77, 0.86) and 0.91 (0.85, 0.95), respectively. In joint-based evaluations, they were 0.83 (0.79, 0.86) and 0.88 (0.83, 0.92), respectively. At short disease duration (⩽6 weeks), the pooled (95% CI) sensitivity and specificity at the joint level were 0.55 (0.46, 0.64) and 0.89 (0.84, 0.94), respectively. CONCLUSION: DECT has a high diagnostic accuracy in established gout, but its diagnostic sensitivity is low in subjects with recent onset gout.
OBJECTIVE: This study aimed to assess the utility of dual energy CT (DECT) for diagnosing gout. METHODS: A systematic literature search was performed in PubMed, EMBASE and Cochrane Library. Studies evaluating the utility of DECT for diagnosing gout were included. Reference standards were detection of monosodium urate crystals at SF assessment or a validated set of criteria. The methodological quality of studies was evaluated according to the Quality Assessment of Diagnostic Accuracy Studies (QUADAS)-2 criteria. Data from person-based and joint-/localization-based evaluations were pooled separately, and subgroup analyses for disease stage/duration and reference standard were performed. RESULTS: Ten studies were included; in person-based evaluations, the pooled (95% CI) sensitivity and specificity were 0.81 (0.77, 0.86) and 0.91 (0.85, 0.95), respectively. In joint-based evaluations, they were 0.83 (0.79, 0.86) and 0.88 (0.83, 0.92), respectively. At short disease duration (⩽6 weeks), the pooled (95% CI) sensitivity and specificity at the joint level were 0.55 (0.46, 0.64) and 0.89 (0.84, 0.94), respectively. CONCLUSION: DECT has a high diagnostic accuracy in established gout, but its diagnostic sensitivity is low in subjects with recent onset gout.
Authors: Christoph Stern; Dimitri N Graf; Samy Bouaicha; Karl Wieser; Andrea B Rosskopf; Reto Sutter Journal: Skeletal Radiol Date: 2022-02-11 Impact factor: 2.128
Authors: Jennifer S Weaver; Ernest R Vina; Peter L Munk; Andrea S Klauser; Jamie M Elifritz; Mihra S Taljanovic Journal: J Clin Med Date: 2021-12-29 Impact factor: 4.241
Authors: Maria Sotniczuk; Anna Nowakowska-Płaza; Jakub Wroński; Małgorzata Wisłowska; Iwona Sudoł-Szopińska Journal: J Clin Med Date: 2022-09-05 Impact factor: 4.964
Authors: Sara Nysom Christiansen; Felix Christoph Müller; Mikkel Østergaard; Ole Slot; Jakob M Møller; Henrik F Børgesen; Kasper Kjærulf Gosvig; Lene Terslev Journal: Arthritis Res Ther Date: 2020-09-11 Impact factor: 5.156